Health Economic Evaluation And Hospital Procurement Decisions
Jul 14, 2026
https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812
Selecting between disposable and reusable biopsy needles involves a complex trade-off between cost, efficiency, infection risk, and patient satisfaction. This section provides a health-economic analysis for hospital administrators.
1. Cost Component Comparison
|
Cost Item |
Disposable Biopsy Needles |
Reusable Biopsy Needles |
|---|---|---|
|
Direct Purchase Cost |
High (Ongoing consumption) |
Low (High initial CAPEX, low amortized cost) |
|
Reprocessing Cost |
None |
High (Labor, Water, Power, Chemicals, Sterilization, Packaging, Equipment Depreciation) |
|
Inventory Cost |
High (Stock variety, warehouse space) |
Low (Fewer units, slow turnover) |
|
Waste Disposal Cost |
High (Sharps/biomedical waste fees) |
Low (Minimal packaging waste) |
|
Potential Loss Cost |
Low (No damage/loss risk) |
High (Replacement cost for lost/damaged units) |
2. Hidden Costs and Benefit Analysis
- Time Efficiency: Disposables are "open-and-use," saving nursing time on cleaning/packing/sterilizing, significantly improving OR/clinic turnover. In high-volume centers, time savings are substantial.
- Infection Risk Cost: Reusables carry a theoretical (though low) cross-contamination risk. The financial and reputational fallout from a single infection outbreak far outweighs disposable costs.
- Performance Consistency: Disposables guarantee a factory-sharp edge every procedure, ensuring consistent sample quality and lower insertion force. Reusable needles dull with use, potentially compromising samples and increasing patient discomfort.
- Management Complexity: Reusable programs demand complex logistics (tracking, reprocessing, sterilization) and dedicated CSSD staffing. Disposables simplify inventory management.
3. Decision Recommendations by Facility Size
Large Tertiary / Cancer Centers:
- Recommendation:Primarily Disposable, supplemented by Reusable (special cases).
- Rationale:High patient volume demands efficiency; research/teaching require top-tier specimen quality; budgets accommodate耗材 costs; stringent infection control priorities.
Mid-Sized Secondary / Maternal-Child Hospitals:
- Recommendation:Hybrid Model. Disposables for routine biopsies; Reusables for complex cases/research.
- Rationale:Balance cost and efficiency; transition gradually toward disposables.
Primary Care Clinics / Small Practices:
- Recommendation:Reusable (if offering the service).
- Rationale:Low case volume makes disposable inventory management costly; cost sensitivity is high. Prerequisite:Must possess certified sterilization capabilities.
4. Impact of Insurance Policy (Focus on China)
Most regional insurance schemes classify biopsy needles as "consumables," partially reimbursed. Healthcare payment reforms (e.g., DRGs/DIP) impose stricter cost controls. Hospitals must leverage Group Purchasing Organizations (GPO) and Volume-Based Procurement (VBP) to lower disposable costs, offsetting financial pressures.
5. Future Trend: Rebalancing Cost and Value
VBP continues to drive down disposable needle prices, eroding the cost advantage of reusables. Simultaneously, robotic-assisted biopsies mandate single-use proprietary instruments. Consequently, disposables represent the dominant future trend. Hospital administrators should align procurement strategies accordingly, emphasizing精细化 cost management.
nts, enhance diagnostic accuracy, mitigate legal risks, and uphold institutional reputation.
